Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,948
Total Claims
$747K
Drug Cost
1,150
Beneficiaries
$649
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-39%
Cost per patient vs peers
$649 vs $1,068 avg
+43%
Brand preference vs peers
12.9% vs 9.0% avg
Brand vs Generic
Brand: 2,292 claims · $689K
Generic: 15,514 claims · $56K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 360 | $181K |
| Apixaban | 151 | $88K |
| Linagliptin | 68 | $61K |
| Alogliptin Benzoate | 82 | $23K |
| Fluticasone Propion/Salmeterol | 54 | $22K |
| Empaglifloz/Linaglip/Metformin | 24 | $20K |
| Dabigatran Etexilate Mesylate | 48 | $20K |
| Tiotropium Br/Olodaterol Hcl | 54 | $19K |
| Sacubitril/Valsartan | 19 | $14K |
| Dulaglutide | 14 | $14K |
| Linagliptin/Metformin Hcl | 17 | $13K |
| Empagliflozin/Metformin Hcl | 14 | $13K |
| Empagliflozin/Linagliptin | 11 | $12K |
| Semaglutide | 12 | $12K |
| Budesonide/Formoterol Fumarate | 29 | $12K |
Prescribing Profile
Patient Profile
78
Avg Age
65%
Female
1.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data